Publications by authors named "Belen De la Morena-Barrio"

Background: Protein-coding genes have been considered the functional part of the genome, although they represent only 2% of the genome. In contrast, more than 90% of the genome produces non-coding RNA (ncRNA), including antisense (AS) genes, a type of long non-coding genes (encoding transcripts > 200 nucleotides) located on the opposite strand of coding genes. Therefore, antisense RNA (asRNA) can be complementary to the counterpart sense RNA, supporting a regulatory role with potential pathogenic consequences, as their deregulation has been associated with cardiovascular disease, cancer, and diabetes.

View Article and Find Full Text PDF

Serine protease inhibitors (serpins) include thousands of structurally conserved proteins playing key roles in many organisms. Mutations affecting serpins may disturb their conformation, leading to inactive forms. Unfortunately, conformational consequences of serpin mutations are difficult to predict.

View Article and Find Full Text PDF

Background: Biallelic variants in EYS are the major cause of autosomal recessive retinitis pigmentosa (arRP) in certain populations, a clinically and genetically heterogeneous disease that may lead to legal blindness. EYS is one of the largest genes (~ 2 Mb) expressed in the retina, in which structural variants (SVs) represent a common cause of disease. However, their identification using short-read sequencing (SRS) is not always feasible.

View Article and Find Full Text PDF
Article Synopsis
  • Genetic diagnosis of inherited platelet disorders (IPDs) often relies on high-throughput sequencing (HTS), but this method can miss important genetic variations.
  • This study evaluated nanopore long-read DNA sequencing as a more effective way to identify structural variants in patients previously diagnosed with Glanzmann thrombasthenia and Hermansky-Pudlak syndrome, where HTS had failed.
  • Nanopore sequencing successfully uncovered complex genetic changes and allowed for detailed identification of variants, demonstrating its value as a complementary diagnostic tool for IPDs.
View Article and Find Full Text PDF
Article Synopsis
  • * Using long-read nanopore sequencing, researchers identified thousands of TEs in the genomes of 24 patients with antithrombin deficiency, revealing many insertions and deletions not recorded in existing databases.
  • * The study found a significant impact of these TEs on genes related to neuron functions and autism, highlighting the importance of mapping TEs for understanding genetic disorders.
View Article and Find Full Text PDF
Article Synopsis
  • Congenital factor XI (FXI) deficiency is often overlooked but provides some natural protection against blood clots, with most genetic defects in the F11 gene being single-nucleotide variants.
  • A study involving 93 FXI deficiency patients over 25 years identified 30 genetic variants, including three significant structural variants (SVs), suggesting these SVs play a vital role in the disorder's molecular pathology.
  • The research emphasizes the need for advanced detection methods, particularly long-read sequencing, to identify these SVs effectively due to their diverse nature and potential to arise spontaneously.
View Article and Find Full Text PDF

Multiplex ligation-dependent probe amplification (MLPA) identifies genetic structural variants in in 5% of cases with antithrombin deficiency (ATD), the most severe congenital thrombophilia. Our aim was to unravel the utility and limitations of MLPA in a large cohort of unrelated patients with ATD (N = 341). MLPA identified 22 structural variants (SVs) causing ATD (6.

View Article and Find Full Text PDF

Introduction: Whole-genome sequencing using nanopore technologies can uncover structural variants, which are DNA rearrangements larger than 50 base pairs. Nanopore technologies can also characterize their boundaries with single-base accuracy, owing to the kilobase-long reads that encompass either full variants or their junctions. Other methods, such as next-generation short read sequencing or PCR assays, are limited in their capabilities to detect or characterize structural variants.

View Article and Find Full Text PDF

Antithrombin, a major endogenous anticoagulant, is a serine protease inhibitor (serpin). We characterized the biological and clinical impact of variants involving C-terminal antithrombin. We performed comprehensive molecular, cellular, and clinical characterization of patients with C-terminal antithrombin variants from a cohort of 444 unrelated individuals with confirmed antithrombin deficiency.

View Article and Find Full Text PDF
Article Synopsis
  • The study emphasizes the importance of identifying inherited antithrombin deficiency (ATD) to prevent serious health issues like blood clots.
  • The researchers used long-read whole-genome sequencing on a group of patients with unresolved genetic tests related to ATD, successfully identifying all previously detected structural variants and unveiling a complex rearrangement previously misclassified.
  • Their findings contributed new insights into the molecular mechanisms of ATD, highlighting a novel retroelement insertion and demonstrating the effectiveness of advanced sequencing technologies in genetic research.
View Article and Find Full Text PDF

Antithrombin deficiency, the most severe congenital thrombophilia, might be underestimated, as some pathogenic variants are not detected by routine functional methods. We have identified 2 new SERPINC1 variants, p.Glu227Lys and p.

View Article and Find Full Text PDF

Inherited antithrombin deficiency, the most severe form of thrombophilia, is predominantly caused by variants in SERPINC1. Few causal structural variants have been described, usually detected by multiplex ligation-dependent probe amplification or cytogenetic arrays, which only define the gain or loss and the approximate size and location. This study has done a complete dissection of the structural variants affecting SERPINC1 of 39 unrelated patients with antithrombin deficiency using multiplex ligation-dependent probe amplification, comparative genome hybridization array, long-range PCR, and whole genome nanopore sequencing.

View Article and Find Full Text PDF

Antithrombin deficiency, the most severe thrombophilia, might be underestimated, since it is only investigated in cases with consistent functional deficiency or family history. We have analyzed 444 consecutive, unrelated cases, from 1998 to 2021, with functional results supporting antithrombin deficiency in at least one sample. Plasma antithrombin was evaluated by functional and biochemical methods in at least two samples.

View Article and Find Full Text PDF
Article Synopsis
  • Atresia of the inferior vena cava (IVC) is a rare congenital condition linked to a high risk of blood clots, possibly due to thrombosis occurring during fetal development.
  • A study evaluated the connection between IVC atresia and severe thrombophilia, particularly in patients with the homozygous SERPINC1 variant, identifying IVC abnormalities in 70.8% of those analyzed.
  • The findings suggest that a thrombosis in fetal vessels might cause IVC atresia, prompting further research into the relationship between severe thrombophilia and this vascular defect.
View Article and Find Full Text PDF

SARS-CoV-2 infection increases the risk of thrombosis by different mechanisms not fully characterized. Although still debated, an increase in D-dimer has been proposed as a first-line hemostasis test associated with thromboembolic risk and unfavorable prognosis. We aim to systematically and comprehensively evaluate the association between thrombin generation parameters and the inflammatory and hypercoagulable state, as well as their prognostic value in COVID-19 patients.

View Article and Find Full Text PDF

Background:  Hereditary antithrombin deficiency is a rare autosomal-dominant disorder predisposing to recurrent venous thromboembolism (VTE). To date, only two founder mutations have been described.

Objectives:  We investigated the antithrombin p.

View Article and Find Full Text PDF

Background: Congenital disorder of glycosylation (CDG) type I is a group of rare disorders caused by recessive mutations in up to 25 genes that impair the N-glycan precursor formation and its transfer to proteins resulting in hypoglycosylation of multiple proteins. Congenital disorder of glycosylation causes multisystem defects usually with psychomotor delay that is diagnosed in the infancy. We aim to supply further evidences supporting that CDG may be underestimated.

View Article and Find Full Text PDF

Pediatric thromboembolism (≤18 years) is very rare (0.07-0.14/10,000/year) but may be more prevalent in children with severe thrombophilia (protein C, protein S or antithrombin deficiency).

View Article and Find Full Text PDF

Introduction: Factor XI (FXI) deficiency is a mild bleeding disorder, common among Ashkenazis, that may be underestimated in Caucasians. Management of FXI deficiency in women is a challenge, due to its unpredictable bleeding tendency and the little evidence available on this issue.

Objective: To describe gynaecological/obstetrical bleeding complications and to analyze the effectiveness and safety of the antihaemorrhagic treatment among women with FXI deficiency.

View Article and Find Full Text PDF